At the close of the recent quarter, Skyline Medical Inc. (NASDAQ:SKLN)‘s balance sheet demonstrated total assets worth $5.47M. Compared to the previous period, the debt increased/decreased by falling.
Skyline Medical Inc.’s total liabilities closing the latest quarter was $1.48M.
Let’s look into the technical of the stock
The Barchart Technical Opinion rating is a 32% Sell with a Weakening short term outlook on maintaining the current direction. Longer term, the trend strength is Weak. Long term indicators fully support a continuation of the trend. The market is approaching oversold territory. Be watchful of a trend reversal.
The assets that the firm listed at the close of the recent quarter comprised cash balance of 2.09M%. Net operating cash from the previous quarter was $(1.16M), resulting in free cash flow of $(1.18M). Compared to the previous period, net change in case was $322,318.
The cash that Skyline Medical Inc. generated in the previous quarter stemmed from sales of 175,166%, which increased 0.45%% in the same quarter, a year ago.
It cost Skyline Medical Inc. some $36,992 to generate the sales of 175,166% reported in the previous quarter as the cost of sales. After discounting the cost of sales in the income computations, Skyline Medical Inc. emerged with gross income of $138,174.
After considering other operating expenses, the firm closed with a net income figure. When that amount divided by the number of outstanding shares it closed up with EPS (earnings per share) of $(0.21). For perspective on how Skyline Medical Inc. reached at the EPS figure, shareholders should know that the firm closed the last quarter with diluted due shares of 6.45M.
Skyline Medical Inc. (NASDAQ:SKLN) (“Skyline” or “the Company”), producer of the FDA-approved STREAMWAY(R) System for automated, direct-to-drain medical fluid disposal, announces that its European Authorized Representative, Emergo Europe B.V., has notified the Dutch Competent Authority that the Company’s STREAMWAY System meets all requirements and can now be affixed with the CE mark and marketed in 32 European countries.